Pfizer Inc. (NYSE:PFE)

The period under review demonstrates significant fluctuations in economic profit. Net operating profit after taxes (NOPAT) exhibited substantial growth initially, followed by a considerable decline and subsequent recovery, though not to initial levels. Invested capital increased markedly before decreasing and stabilizing. The cost of capital remained relatively stable throughout the period, with a slight initial increase followed by a decrease and leveling off.

Economic Profit Trend

Economic profit began at US$9,977 million in 2021, increasing to US$20,171 million in 2022. A dramatic reversal occurred in 2023, resulting in an economic loss of US$14,392 million. This trend partially corrected in 2024 and 2025, with economic losses of US$4,297 million and US$4,879 million respectively, indicating continued underperformance relative to the cost of capital.

NOPAT Analysis

NOPAT increased significantly from US$18,394 million in 2021 to US$31,018 million in 2022. However, it experienced a substantial decrease in 2023, reporting a loss of US$1,277 million. NOPAT recovered to US$7,374 million in 2024 and remained relatively stable at US$7,193 million in 2025. This volatility in NOPAT is a primary driver of the fluctuations in economic profit.

Invested Capital and Cost of Capital Relationship

Invested capital rose from US$87,670 million in 2021 to US$110,746 million in 2022, and further increased to US$154,882 million in 2023. It then decreased to US$135,342 million in 2024 and stabilized at US$139,753 million in 2025. The cost of capital was 9.60% in 2021, increasing to 9.79% in 2022, then decreasing to 8.47% in 2023, and stabilizing around 8.6% for 2024 and 2025. The increasing invested capital in the early years, coupled with a relatively stable cost of capital, likely contributed to the initial growth in economic profit. The subsequent decline in NOPAT, despite a decreasing cost of capital in 2023, overwhelmed any positive effects from the cost of capital reduction.

The substantial decline in economic profit in 2023 warrants further investigation. While the cost of capital decreased, the significant drop in NOPAT resulted in a considerable economic loss. The subsequent years show a failure to return to the profitability levels observed in 2021 and 2022, despite a reduction in invested capital from its peak in 2023.

Net income attributable to Pfizer Inc. common shareholders and Net Operating Profit After Taxes (NOPAT) exhibited significant fluctuations between 2021 and 2025. While net income demonstrated an initial increase followed by a substantial decline, NOPAT mirrored this pattern with even more pronounced volatility, including a negative value in 2023.

Net Income Trend

Net income attributable to Pfizer Inc. common shareholders increased from US$21,979 million in 2021 to US$31,372 million in 2022, representing a substantial year-over-year growth. However, a dramatic decrease was observed in 2023, falling to US$2,119 million. A partial recovery occurred in 2024, with net income reaching US$8,031 million, followed by a slight decrease to US$7,771 million in 2025.

NOPAT Trend

NOPAT followed a similar trajectory to net income, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant shift occurred in 2023, with NOPAT becoming negative at US$-1,277 million. A recovery was then seen in 2024, rising to US$7,374 million, and continuing to US$7,193 million in 2025. The magnitude of the decline and subsequent recovery in NOPAT was greater than that observed in net income.

Relationship between Net Income and NOPAT

While both metrics generally moved in the same direction, the divergence in 2023 is noteworthy. The substantial negative NOPAT value suggests that operating profits, after accounting for taxes, were insufficient to cover the cost of capital employed during that year, despite a positive, albeit significantly reduced, net income. This indicates that factors beyond core operational profitability, such as financing or non-operating items, played a larger role in determining net income in 2023.

The period between 2024 and 2025 shows relative stabilization in both metrics, although NOPAT remains considerably lower than its peak in 2022. Further investigation would be required to understand the underlying drivers of these fluctuations and their implications for the company’s long-term financial performance.

The provision for taxes on income exhibits significant volatility over the observed period. Beginning at US$1,852 million in 2021, it increased substantially to US$3,328 million in 2022 before experiencing a dramatic shift to a benefit of negative US$1,115 million in 2023. This benefit continued, albeit at a smaller magnitude, in 2024 (-US$28 million) and 2025 (-US$267 million). In contrast, cash operating taxes demonstrate a more stable, though fluctuating, pattern.

Cash Operating Taxes Trend

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a substantial rise. A subsequent decrease was noted in 2023, falling to US$2,113 million. Values then recovered somewhat in 2024 and 2025, reaching US$2,426 million and US$2,334 million respectively. While fluctuating, the values in 2024 and 2025 remain considerably below the 2021 and 2022 levels.

The divergence between the provision for taxes on income and cash operating taxes is noteworthy. The large benefit recorded in the provision for taxes in 2023, 2024, and 2025 suggests the utilization of tax loss carryforwards or other tax planning strategies, resulting in a reduced accounting expense despite continued cash outflows for taxes. The cash operating taxes, while decreasing from 2022 to 2023, remained positive throughout the period, indicating actual cash payments were made to tax authorities even when the accounting provision reflected a benefit.

Relationship between Provision and Cash Taxes

The difference between the provision for taxes on income and cash operating taxes widened considerably in 2023, 2024, and 2025. This indicates a growing deferral of taxable income or an increasing benefit from tax credits or loss carryforwards. The substantial difference highlights the impact of non-cash tax items on the reported income tax expense.

The observed trends suggest a complex tax position, potentially involving significant tax planning and the utilization of deferred tax assets. Further investigation into the specific drivers of the tax benefit and the nature of the deferred tax items would be beneficial for a complete understanding of the company’s tax strategy and its impact on financial performance.

The reported invested capital demonstrates a clear increasing trend over the observed period, followed by a stabilization and slight increase. A significant rise is noted between 2021 and 2023, while subsequent years show a more moderate pattern. This analysis details the observed movements in invested capital alongside its constituent components: total reported debt & leases and total shareholders’ equity.

Invested Capital Trend

Invested capital increased substantially from US$87,670 million in 2021 to US$154,882 million in 2023, representing a growth of approximately 76.8%. This growth slowed considerably in 2024, with invested capital decreasing to US$135,342 million. A modest increase to US$139,753 million was observed in 2025. The 2024 decrease suggests a potential shift in capital allocation strategy or a reduction in capital-intensive projects.

Debt & Leases

Total reported debt & leases decreased from US$41,395 million in 2021 to US$39,046 million in 2022. However, a substantial increase occurred in 2023, reaching US$75,041 million. This was followed by a decrease to US$66,993 million in 2024 and a slight increase to US$67,416 million in 2025. The 2023 surge in debt likely contributed significantly to the overall increase in invested capital during that year.

Shareholders’ Equity

Total shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022, indicating strong equity growth. A decrease was then observed in 2023, falling to US$89,014 million, and continued to decline in 2024 and 2025, reaching US$88,203 million and US$86,476 million respectively. This consistent decline in shareholders’ equity over the latter part of the period partially offset the impact of increased debt on invested capital.

The interplay between debt and equity significantly influences the overall invested capital. While debt increased substantially in 2023, the subsequent decrease in shareholders’ equity moderated the growth in invested capital in 2024 and 2025. The stabilization of invested capital in the later years suggests a balancing act between debt financing and equity returns.

The economic spread ratio exhibited a fluctuating pattern over the five-year period. Initially, the ratio demonstrated substantial growth, followed by a significant decline into negative territory. Economic profit experienced a similar trajectory, initially increasing and then becoming negative.

Economic Spread Ratio Trend

The economic spread ratio began at 11.38% in 2021 and increased to 18.21% in 2022, indicating an improved ability to generate returns exceeding the cost of capital. However, a sharp reversal occurred in 2023, with the ratio plummeting to -9.29%. This negative trend continued in subsequent years, reaching -3.17% in 2024 and -3.49% in 2025. The consistent negative values in the latter years suggest that invested capital is generating returns below the company’s cost of capital.

Economic Profit and Invested Capital Relationship

Economic profit and invested capital moved in divergent directions. While economic profit rose significantly from 2021 to 2022, invested capital also increased, though at a slower rate. The subsequent decline in economic profit, culminating in negative values in 2023, 2024, and 2025, coincided with continued increases in invested capital through 2023, followed by a slight decrease in 2024 and a small increase in 2025. This suggests that increases in invested capital are not translating into proportional increases in economic profit, contributing to the declining economic spread ratio.

The shift from positive to negative economic spread ratios, coupled with the increasing invested capital base, warrants further investigation into the factors driving profitability and capital allocation decisions. The sustained negative economic spread ratio indicates a potential erosion of shareholder value.

The economic profit margin exhibited significant fluctuations over the five-year period. Initially positive and increasing, it transitioned to negative values and remained so through the end of the observed timeframe. This analysis details the observed trends in economic profit, revenues, and the resulting economic profit margin.

Economic Profit

Economic profit demonstrated a substantial increase from 2021 to 2022, rising from US$9,977 million to US$20,171 million. However, this positive trend reversed sharply in 2023, with economic profit declining to a loss of US$14,392 million. Losses continued in subsequent years, reaching US$4,297 million in 2024 and US$4,879 million in 2025, indicating a sustained period of value destruction.

Revenues

Revenues increased notably from 2021 to 2022, growing from US$82,145 million to US$101,175 million. A significant decrease in revenues occurred in 2023, falling to US$59,553 million. Revenues experienced a modest recovery in 2024, reaching US$63,627 million, but remained below the 2022 peak. Revenue remained relatively stable in 2025 at US$62,579 million.

Economic Profit Margin

The economic profit margin mirrored the trend in economic profit. It increased from 12.15% in 2021 to 19.94% in 2022, reflecting improved profitability relative to revenue. The margin then plummeted to -24.17% in 2023, coinciding with the substantial economic loss. The margin remained negative in 2024 (-6.75%) and 2025 (-7.80%), suggesting continued underperformance in generating economic profit despite a partial revenue recovery. The consistent negative margin indicates that the cost of capital exceeded the returns generated from operations during these later years.

The divergence between revenue and economic profit trends is particularly noteworthy. While revenues initially increased, the subsequent decline in economic profit, and the resulting negative economic profit margin, suggests increasing costs or a less efficient allocation of capital. The sustained negative economic profit margin from 2023 onwards warrants further investigation into the underlying drivers of profitability and capital efficiency.